Advances in Pulmonary Delivery of Biologics

This podcast features a panel discussion with pharma and biotech leaders about the past and future direction of pulmonary delivery of biologics. Specifically, the panelists discuss:The benefits and costs of different formulation approaches to deliver inhaled therapeutics what needs to be developed to enable more biologicsDifferent device approaches including nebulizers, soft mist inhalers, dry powder inhalers and moreFactors driving new platform and therapeutic development including patient-centricity, legacy technology and time to marketNext-generation inhaled therapeutics like mRNA vaccinesTo learn more about the PODD conference, please visit Drug-Delivery.org.